[Therapy with nonsteroidal anti-inflammatory drugs]

Area of Science:

• Pharmacology
• Gastroenterology
• Nephrology

Background:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed for pain and inflammation.
• Their therapeutic effects stem from inhibiting prostaglandin synthesis via cyclooxygenase (COX) enzymes.
• NSAIDs pose significant risks, particularly gastrointestinal and renal side effects.

Purpose of the Study:

• To evaluate the efficacy and safety of NSAIDs, focusing on the role of COX isoforms.
• To compare the risks associated with traditional NSAIDs versus COX-2 selective inhibitors.
• To provide guidance on NSAID use in patients with increased risk factors.

Main Methods:

• Review of existing literature on NSAID mechanisms of action.
• Analysis of clinical data comparing COX-1 and COX-2 inhibition effects.
• Examination of side effect profiles and risk mitigation strategies for NSAIDs.

Main Results:

• NSAIDs inhibit both COX-1 and COX-2 enzymes; COX-2 inhibition provides therapeutic benefits, while COX-1 inhibition causes most side effects.
• COX-2 selective inhibitors offer comparable pain relief to traditional NSAIDs with reduced gastrointestinal risks.
• Caution and careful monitoring are essential when using NSAIDs in patients with renal impairment or other risk factors.

Conclusions:

• Selective COX-2 inhibition represents a safer alternative for pain management in many patients.
• Risk stratification and prophylactic measures are crucial for patients requiring NSAID therapy.
• Individual patient factors, such as renal function and concurrent medications, necessitate tailored treatment approaches.